J106-0134 Screening compound: 1-(1H-indazol-3-yl)-5-oxo-N-(5-propyl-1,3,4-thiadiazol-2-yl)pyrrolidine-3-carboxamide

J106-0134 Screening compound: 1-(1H-indazol-3-yl)-5-oxo-N-(5-propyl-1,3,4-thiadiazol-2-yl)pyrrolidine-3-carboxamide
J106-0134 Screening compound: 1-(1H-indazol-3-yl)-5-oxo-N-(5-propyl-1,3,4-thiadiazol-2-yl)pyrrolidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J106-0134
1-(1H-indazol-3-yl)-5-oxo-N-(5-propyl-1,3,4-thiadiazol-2-yl)pyrrolidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J106-0134

Molecular Formula

C17H18N6O2S (C17 H18 N6 O2 S)

Compound Name

1-(1H-indazol-3-yl)-5-oxo-N-(5-propyl-1,3,4-thiadiazol-2-yl)pyrrolidine-3-carboxamide

IUPAC name

1-(1H-indazol-3-yl)-5-oxo-N-(5-propyl-134-thiadiazol-2-yl)pyrrolidine-3-carboxamide

SMILES

CCCc1nnc(NC(C(CC2=O)CN2c2n[nH]c3c2cccc3)=O)s1

InChI

InChI=1S/C17H18N6O2S/c1-2-5-13-20-22-17(26-13)18-16(25)10-8-14(24)23(9-10)15-11-6-3-4-7-12(11)19-21-15/h3-4,6-7,10H,2,5,8-9H2,1H3,(H,19,21)(H,18,22,25)/t10-/m0/s1

InChI Key

VJXLYZLDYXQHHY-JTQLQIEISA-N

MDL Number (MFCD)

MFCD28578197

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

370.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.590

Distribution Coefficient, logD

2.091

Water Solubility, LogSw

-3.01

Polar Surface Area

86.529

Acid Dissociation Constant (pKa)

7.07

Base Dissociation Constant (pKb)

-2.57

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

35.30

J106-0134 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Targets:
  • Proteases
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with J106-0134 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J106-0134?
Check Price and Availability of J106-0134, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J106-0134 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J106-0134
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J106-0134
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J106-0134 available by request